Hypoglycemic brain injury

R C Vannucci1, S J Vannucci

  • 1Department of Pediatrics, The Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, PA 17033-0850, USA.

Insights

Neonatal hypoglycemia, common in at-risk infants, can cause brain damage, especially when severe or combined with asphyxia. The immature brain shows some resistance due to adaptive mechanisms.

Area of Science:

  • Neonatology
  • Pediatric Neurology
  • Neuroscience

Background:

  • Neonatal hypoglycemia is prevalent in infants with asphyxia, diabetic mothers, or intrauterine growth restriction (IUGR).
  • Hypoglycemia presents with varied clinical manifestations, posing a risk for permanent brain damage in newborns.
  • Symptomatic hypoglycemia, particularly when severe or prolonged, is linked to significant neurologic morbidity.

Purpose of the Study:

  • To review the clinical, neuropathologic, and neuro-imaging features of hypoglycemia in newborn infants.
  • To highlight the specific risks and characteristics of symptomatic neonatal hypoglycemia.
  • To discuss the immature brain's response to hypoglycemia.

Main Methods:

  • Review of existing literature on neonatal hypoglycemia.
  • Analysis of clinical presentations, neuropathologic findings, and neuro-imaging data.
  • Examination of experimental data on brain physiology during hypoglycemia.

Main Results:

  • The immature brain exhibits resistance to hypoglycemia due to compensatory mechanisms like increased cerebral blood flow and alternative substrate utilization.
  • Severe, protracted, or recurrent symptomatic hypoglycemia is particularly detrimental to neurologic outcomes.
  • Concomitant hypoxia-ischemia (asphyxia) exacerbates the damaging effects of hypoglycemia on the developing brain.

Conclusions:

  • Neonatal hypoglycemia requires careful monitoring and management, especially in symptomatic infants.
  • The immature brain's adaptive capacity offers some protection but is overcome by severe or combined insults.
  • Understanding these features is crucial for preventing long-term neurologic sequelae.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...